Baxter
BAX
#956
Rank
ยฃ15.14 B
Marketcap
ยฃ29.69
Share price
0.36%
Change (1 day)
-5.08%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Baxter (BAX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : ยฃ14.17 B

According to Baxter's latest financial reports the company's total liabilities are ยฃ14.17 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Baxter - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ15.54 B-16%
2022-12-31ยฃ18.50 B2.66%
2021-12-31ยฃ18.02 B117.94%
2020-12-31ยฃ8.27 B6.78%
2019-12-31ยฃ7.74 B25.86%
2018-12-31ยฃ6.15 B4.05%
2017-12-31ยฃ5.91 B0.46%
2016-12-31ยฃ5.88 B-27.79%
2015-12-31ยฃ8.15 B-29.4%
2014-12-31ยฃ11.55 B13.97%
2013-12-31ยฃ10.13 B22.2%
2012-12-31ยฃ8.29 B5.28%
2011-12-31ยฃ7.87 B13.35%
2010-12-31ยฃ6.95 B12.31%
2009-12-31ยฃ6.18 B-2.75%
2008-12-31ยฃ6.36 B51.67%
2007-12-31ยฃ4.19 B-2.32%
2006-12-31ยฃ4.29 B-12.11%
2005-12-31ยฃ4.88 B-10.22%
2004-12-31ยฃ5.44 B-7.46%
2003-12-31ยฃ5.88 B-1.12%
2002-12-31ยฃ5.94 B30.97%
2001-12-31ยฃ4.54 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ36.82 B 159.80%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ14.75 B 4.11%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ12.57 B-11.31%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ22.64 B 59.71%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.28 B-90.97%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ38.83 B 173.92%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.38 B-76.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ30.14 B 112.65%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ยฃ1.71 B-87.91%๐Ÿ‡บ๐Ÿ‡ธ USA